Target type: molecularfunction
Enables the transfer of protons from one side of a membrane to the other according to the reaction: ATP + H2O + H+(in) -> ADP + phosphate + H+(out), by a rotational mechanism. [RHEA:57721]
Proton-transporting ATPase activity, rotational mechanism, involves the coordinated movement of multiple protein subunits to generate ATP from ADP and inorganic phosphate. This process is driven by the transmembrane movement of protons, which are pumped across a membrane by the enzyme. The enzyme consists of two main components: a membrane-bound F0 subunit and a peripheral F1 subunit. The F0 subunit forms a channel through the membrane, allowing protons to flow through it. This proton flow is coupled to the rotation of a central stalk within the F0 subunit. The central stalk is connected to the F1 subunit, which contains the catalytic sites for ATP synthesis. As the central stalk rotates, it interacts with the catalytic sites, causing them to change conformation and synthesize ATP. This mechanism can be described in three steps:
1. Proton Binding and Rotation: Protons bind to the F0 subunit, causing a conformational change that rotates the central stalk.
2. Stator-Rotor Interaction: The rotating central stalk interacts with the stationary F1 subunit, causing a conformational change in the catalytic sites.
3. ATP Synthesis: The conformational change in the catalytic sites promotes the formation of ATP from ADP and inorganic phosphate.
This rotational mechanism is highly efficient and is responsible for generating the majority of ATP in most living organisms.'
"
Protein | Definition | Taxonomy |
---|---|---|
ATP synthase subunit beta, mitochondrial | An ATP synthase subunit beta, mitochondrial that is encoded in the genome of cow. [OMA:P00829, PRO:DNx] | Bos taurus (cattle) |
V-type proton ATPase subunit B, brain isoform | A V-type proton ATPase subunit B, brain isoform that is encoded in the genome of human. [PRO:DNx, UniProtKB:P21281] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
enoxacin | enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea. Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID. | 1,8-naphthyridine derivative; amino acid; fluoroquinolone antibiotic; monocarboxylic acid; N-arylpiperazine; quinolone antibiotic | antibacterial drug; DNA synthesis inhibitor |
glyburide | glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group. Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide | monochlorobenzenes; N-sulfonylurea | anti-arrhythmia drug; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor; hypoglycemic agent |
n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine | N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine: potassium channel opener | pyridines | |
bms 180448 | BMS 180448: a potassium channel opener with cardioprotective and vasodilator properties; BMS-180426 is enantiomer with no antiischemic activity; structure in first source | ||
cromakalim | 1-benzopyran | ||
bms 191095 | BMS 191095: a mitochondrial K(ATP) opener; structure in first source |